$OM
Outset Medical, Inc.

2020 Q4 Form 10-K Financial Statement

#000156459021014563 Filed on March 22, 2021

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2020 Q2
Revenue $17.25M $13.76M $11.74M
YoY Change 143.43% 423.04% 308.84%
Cost Of Revenue $16.83M $18.88M $16.51M
YoY Change 138.29% 124.88%
Gross Profit $417.0K -$5.126M -$4.764M
YoY Change -115.0% -3.17% 6.58%
Gross Profit Margin 2.42% -37.26% -40.57%
Selling, General & Admin $24.25M $26.43M $14.09M
YoY Change 254.89% 110.33%
% of Gross Profit 5815.35%
Research & Development $7.780M $9.175M $6.053M
YoY Change 60.74% 8.48%
% of Gross Profit 1865.71%
Depreciation & Amortization $1.930M $540.0K $380.0K
YoY Change 168.06% 0.0%
% of Gross Profit 462.83%
Operating Expenses $32.03M $35.61M $20.15M
YoY Change 170.65% 64.05%
Operating Profit -$31.61M -$40.73M -$24.91M
YoY Change 120.78% 48.71%
Interest Expense -$430.0K $428.0K $1.032M
YoY Change -59.12% -412.73%
% of Operating Profit
Other Income/Expense, Net $0.00 -$3.000K -$630.0K
YoY Change -100.53% -1360.0%
Pretax Income -$32.04M -$42.29M -$26.51M
YoY Change 174.96% 55.67%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$32.04M -$42.29M -$26.51M
YoY Change 64.78% 174.6% 55.65%
Net Earnings / Revenue -185.79% -307.46% -225.73%
Basic Earnings Per Share -$0.75 -$3.44 -$4.58
Diluted Earnings Per Share -$0.75 -$3.44 -$4.58
COMMON SHARES
Basic Shares Outstanding 42.70M
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q4 2020 Q3 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $314.9M $344.2M $140.4M
YoY Change
Cash & Equivalents $295.0M $311.3M $141.9M
Short-Term Investments $19.90M $32.90M $2.500M
Other Short-Term Assets $6.200M $4.700M $5.700M
YoY Change
Inventory $18.38M $11.81M $6.500M
Prepaid Expenses
Receivables $6.468M $7.082M $7.200M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $345.9M $367.8M $159.9M
YoY Change 334.31%
LONG-TERM ASSETS
Property, Plant & Equipment $15.00M $14.41M $20.00M
YoY Change 89.97%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.356M $1.977M $5.600M
YoY Change 1553.66%
Total Long-Term Assets $57.92M $58.20M $25.50M
YoY Change 564.2%
TOTAL ASSETS
Total Short-Term Assets $345.9M $367.8M $159.9M
Total Long-Term Assets $57.92M $58.20M $25.50M
Total Assets $403.8M $426.0M $185.4M
YoY Change 357.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.948M $5.062M $3.500M
YoY Change -0.24%
Accrued Expenses $26.60M $22.40M $16.40M
YoY Change
Deferred Revenue $3.201M $4.132M
YoY Change 262.51%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00 $29.40M
YoY Change -100.0%
Total Short-Term Liabilities $36.69M $33.04M $53.60M
YoY Change 47.3%
LONG-TERM LIABILITIES
Long-Term Debt $29.67M $29.65M $0.00
YoY Change 37.63%
Other Long-Term Liabilities $8.900M $9.000M $13.60M
YoY Change
Total Long-Term Liabilities $29.67M $29.65M $13.60M
YoY Change 37.63%
TOTAL LIABILITIES
Total Short-Term Liabilities $36.69M $33.04M $53.60M
Total Long-Term Liabilities $29.67M $29.65M $13.60M
Total Liabilities $75.22M $71.69M $67.20M
YoY Change 47.18%
SHAREHOLDERS EQUITY
Retained Earnings -$494.1M -$462.0M
YoY Change 32.61%
Common Stock $822.7M $816.3M
YoY Change 229695.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $328.6M $354.3M -$334.1M
YoY Change
Total Liabilities & Shareholders Equity $403.8M $426.0M $185.4M
YoY Change 357.0%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2020 Q2
OPERATING ACTIVITIES
Net Income -$32.04M -$42.29M -$26.51M
YoY Change 64.78% 174.6% 55.65%
Depreciation, Depletion And Amortization $1.930M $540.0K $380.0K
YoY Change 168.06% 0.0%
Cash From Operating Activities -$25.84M -$29.12M -$19.17M
YoY Change -18.74% -4.63%
INVESTING ACTIVITIES
Capital Expenditures -$2.660M -$1.460M -$2.190M
YoY Change 171.43% 73.81%
Acquisitions
YoY Change
Other Investing Activities $13.02M -$30.42M $8.500M
YoY Change -77.74% -3.95%
Cash From Investing Activities $10.36M -$31.88M $6.310M
YoY Change -81.99% -16.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -880.0K 259.8M 30.00K
YoY Change 1366.67% -81.25%
NET CHANGE
Cash From Operating Activities -25.84M -29.12M -19.17M
Cash From Investing Activities 10.36M -31.88M 6.310M
Cash From Financing Activities -880.0K 259.8M 30.00K
Net Change In Cash -16.36M 198.8M -12.83M
YoY Change -163.78% 3.89%
FREE CASH FLOW
Cash From Operating Activities -$25.84M -$29.12M -$19.17M
Capital Expenditures -$2.660M -$1.460M -$2.190M
Free Cash Flow -$23.18M -$27.66M -$16.98M
YoY Change -24.79% -9.87%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2020 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020 dei Entity Registrant Name
EntityRegistrantName
Outset Medical, Inc.
CY2020 dei Entity Central Index Key
EntityCentralIndexKey
0001484612
CY2020 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2020Q2 dei Entity Public Float
EntityPublicFloat
0
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
42805772
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2020 dei Entity Small Business
EntitySmallBusiness
false
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2020 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2020 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020 dei Entity File Number
EntityFileNumber
001-39513
CY2020 dei Document Period End Date
DocumentPeriodEndDate
2020-12-31
CY2020 dei Trading Symbol
TradingSymbol
OM
CY2020 us-gaap Operating Expenses
OperatingExpenses
104430000
CY2019 us-gaap Operating Expenses
OperatingExpenses
52505000
CY2018 us-gaap Operating Expenses
OperatingExpenses
40448000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-117467000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-70307000
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-46563000
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2485000
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1709000
CY2018 us-gaap Interest Expense
InterestExpense
4639000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-68279000
CY2018 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-49755000
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-49780000
CY2020 om Net Income Loss Attributable To Common Stockholders Basic And Diluted
NetIncomeLossAttributableToCommonStockholdersBasicAndDiluted
-79324000
CY2019 om Net Income Loss Attributable To Common Stockholders Basic And Diluted
NetIncomeLossAttributableToCommonStockholdersBasicAndDiluted
-85461000
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-4.85
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-99.58
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-100.75
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
16358000
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
858000
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
725000
CY2019 om Increase Decrease In Accrued Warranty Liability
IncreaseDecreaseInAccruedWarrantyLiability
1410000
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
19898000
CY2019Q4 us-gaap Short Term Investments
ShortTermInvestments
33152000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
6468000
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3914000
CY2020Q4 us-gaap Inventory Net
InventoryNet
18384000
CY2019Q4 us-gaap Inventory Net
InventoryNet
4596000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6189000
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1058000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
345911000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
79646000
CY2020Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
33311000
CY2019Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
743000
CY2020 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-0514392
CY2020 dei Entity Address Address Line1
EntityAddressAddressLine1
3052 Orchard Dr.
CY2020 dei Entity Address City Or Town
EntityAddressCityOrTown
San Jose
CY2020 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2020 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95134
CY2020 dei City Area Code
CityAreaCode
669
CY2020 dei Local Phone Number
LocalPhoneNumber
231-8200
CY2020 dei Document Annual Report
DocumentAnnualReport
true
CY2020 dei Document Transition Report
DocumentTransitionReport
false
CY2020 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
294972000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36926000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14998000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7895000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8253000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1356000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
82000
CY2020Q4 us-gaap Assets
Assets
403829000
CY2019Q4 us-gaap Assets
Assets
88366000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4948000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4960000
CY2020Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
16845000
CY2019Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
6956000
CY2020Q4 om Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
7903000
CY2019Q4 om Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
2909000
CY2020Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
2913000
CY2019Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
1702000
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
3201000
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
883000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
882000
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
7500000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
36692000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
24910000
CY2020Q4 om Accrued Interest Noncurrent
AccruedInterestNoncurrent
240000
CY2019Q4 om Accrued Interest Noncurrent
AccruedInterestNoncurrent
217000
CY2020Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
570000
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
134000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
8044000
CY2019Q4 om Redeemable Convertible Preferred Stock Warrant Liability
RedeemableConvertiblePreferredStockWarrantLiability
4285000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
29674000
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
21561000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
328609000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-372187000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
403829000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
88366000
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
922000
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2007000
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
62972000
CY2020Q4 us-gaap Liabilities
Liabilities
75220000
CY2019Q4 us-gaap Liabilities
Liabilities
51107000
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
43000
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
822624000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
357000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
22000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-494059000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-372567000
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
240000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42722000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
922000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
42722000
CY2020 us-gaap Gross Profit
GrossProfit
-13037000
CY2019 us-gaap Gross Profit
GrossProfit
-17802000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28850000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23327000
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
22916000
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
45068000
CY2019 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
20259000
CY2018 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11279000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
30512000
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8919000
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6253000
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
526000
CY2020 us-gaap Interest Expense
InterestExpense
2891000
CY2019 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
735000
CY2019 us-gaap Interest Expense
InterestExpense
4257000
CY2020 om Change In Fair Value Of Redeemable Convertible Preferred Stock Warrant Liability
ChangeInFairValueOfRedeemableConvertiblePreferredStockWarrantLiability
-93000
CY2019 om Change In Fair Value Of Redeemable Convertible Preferred Stock Warrant Liability
ChangeInFairValueOfRedeemableConvertiblePreferredStockWarrantLiability
3800000
CY2018 om Change In Fair Value Of Redeemable Convertible Preferred Stock Warrant Liability
ChangeInFairValueOfRedeemableConvertiblePreferredStockWarrantLiability
-262000
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1567000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-121492000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20000
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
25000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-121492000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-68299000
CY2020 om Adjustment Of Redeemable Capital Shares To Redemption Value
AdjustmentOfRedeemableCapitalSharesToRedemptionValue
362000
CY2019 om Adjustment Of Redeemable Capital Shares To Redemption Value
AdjustmentOfRedeemableCapitalSharesToRedemptionValue
134760000
CY2018 om Adjustment Of Redeemable Capital Shares To Redemption Value
AdjustmentOfRedeemableCapitalSharesToRedemptionValue
23300000
CY2019 om Gain On Extinguishment Of Redeemable Convertible Preferred Stock Before Cost Adjustment
GainOnExtinguishmentOfRedeemableConvertiblePreferredStockBeforeCostAdjustment
117598000
CY2020 om Deemed Dividend On Settlement Of Accrued Dividend
DeemedDividendOnSettlementOfAccruedDividend
42530000
CY2018 om Net Income Loss Attributable To Common Stockholders Basic And Diluted
NetIncomeLossAttributableToCommonStockholdersBasicAndDiluted
-73080000
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-21000
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
82000
CY2018 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-37000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-121513000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-68217000
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-49817000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-215937000
CY2018 us-gaap Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
23299000
CY2018 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
315000
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
788000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-287950000
CY2019 om Exercise Of Warrants For Common Stock
ExerciseOfWarrantsForCommonStock
76000
CY2019 us-gaap Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
134760000
CY2019 om Gain On Extinguishment Of Redeemable Convertible Preferred Stock
GainOnExtinguishmentOfRedeemableConvertiblePreferredStock
117417000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
364000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
883000
CY2020 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
41763000
CY2020 us-gaap Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock
362000
CY2020 om Conversion Of Redeemable Convertible Preferred Stock Warrants To Common Stock Warrants Value
ConversionOfRedeemableConvertiblePreferredStockWarrantsToCommonStockWarrantsValue
1252000
CY2020 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
456561000
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
254805000
CY2020 us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
3126000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1195000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
21439000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3159000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1484000
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1069000
CY2020 om Non Cash Lease Expense
NonCashLeaseExpense
596000
CY2019 om Non Cash Lease Expense
NonCashLeaseExpense
451000
CY2018 om Non Cash Lease Expense
NonCashLeaseExpense
425000
CY2020 om Non Cash Interest Expense
NonCashInterestExpense
641000
CY2019 om Non Cash Interest Expense
NonCashInterestExpense
893000
CY2018 om Non Cash Interest Expense
NonCashInterestExpense
1348000
CY2020 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-50000
CY2019 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
983000
CY2018 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
779000
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
12000
CY2019 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
59000
CY2020 om Provision For Inventories
ProvisionForInventories
534000
CY2019 om Provision For Inventories
ProvisionForInventories
326000
CY2018 om Provision For Inventories
ProvisionForInventories
442000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
21439000
CY2020 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-235000
CY2019 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-293000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
21439000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
883000
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
788000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2566000
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2886000
CY2018 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
552000
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
16287000
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5020000
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2212000
CY2020 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
6245000
CY2019 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
228000
CY2018 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
270000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
737000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
802000
CY2018 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2675000
CY2020 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
9889000
CY2019 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
3119000
CY2018 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
647000
CY2020 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
4798000
CY2019 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
974000
CY2018 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
457000
CY2020 om Increase Decrease In Accrued Warranty Liability
IncreaseDecreaseInAccruedWarrantyLiability
1211000
CY2018 om Increase Decrease In Accrued Warranty Liability
IncreaseDecreaseInAccruedWarrantyLiability
-443000
CY2020 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
2754000
CY2018 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-55000
CY2020 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-217000
CY2020 om Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
77000
CY2019 om Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-505000
CY2018 om Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-464000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-99015000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-70292000
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-46442000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9108000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3293000
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1766000
CY2020 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
32884000
CY2019 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
91878000
CY2018 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
132310000
CY2020 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
45908000
CY2019 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
169468000
CY2018 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
65300000
CY2020 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
31000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3947000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
74297000
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-68776000
CY2020 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
254805000
CY2018 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
134567000
CY2020 om Proceeds From Issuance Of Cash Exercise Of Redeemable Convertible Preferred Stock Warrant
ProceedsFromIssuanceOfCashExerciseOfRedeemableConvertiblePreferredStockWarrant
4288000
CY2020 us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
126758000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1195000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
363000
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
314000
CY2020 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
29630000
CY2020 om Repayment Of Term Loan And Extinguishment Costs
RepaymentOfTermLoanAndExtinguishmentCosts
30985000
CY2020 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
9000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
883000
CY2019 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
76000
CY2019 om Payment Of Redeemable Convertible Preferred Stock Issuance Costs
PaymentOfRedeemableConvertiblePreferredStockIssuanceCosts
181000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
385682000
CY2019 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
9000
CY2018 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
9000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
249000
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
134872000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
290614000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
4254000
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
19654000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
37669000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
33415000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13761000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
328283000
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
19000
CY2019 us-gaap Income Taxes Paid
IncomeTaxesPaid
35000
CY2018 us-gaap Income Taxes Paid
IncomeTaxesPaid
9000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
3270000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
3352000
CY2018 us-gaap Interest Paid Net
InterestPaidNet
3292000
CY2019 om Cash Paid For Amounts Included In Measurement Of Operating Lease Liabilities
CashPaidForAmountsIncludedInMeasurementOfOperatingLeaseLiabilities
505000
CY2018 om Cash Paid For Amounts Included In Measurement Of Operating Lease Liabilities
CashPaidForAmountsIncludedInMeasurementOfOperatingLeaseLiabilities
464000
CY2020 om Capital Expenditures Included In Accounts Payable And Accrued Expenses
CapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses
323000
CY2019 om Capital Expenditures Included In Accounts Payable And Accrued Expenses
CapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses
867000
CY2018 om Capital Expenditures Included In Accounts Payable And Accrued Expenses
CapitalExpendituresIncludedInAccountsPayableAndAccruedExpenses
83000
CY2020 om Transfer Of Property And Equipment To Inventories
TransferOfPropertyAndEquipmentToInventories
2131000
CY2019 om Transfer Of Property And Equipment To Inventories
TransferOfPropertyAndEquipmentToInventories
3119000
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
8849000
CY2020 om Adjustment To Redemption Value On Redeemable Convertible Preferred Stock
AdjustmentToRedemptionValueOnRedeemableConvertiblePreferredStock
362000
CY2019 om Adjustment To Redemption Value On Redeemable Convertible Preferred Stock
AdjustmentToRedemptionValueOnRedeemableConvertiblePreferredStock
134760000
CY2018 om Adjustment To Redemption Value On Redeemable Convertible Preferred Stock
AdjustmentToRedemptionValueOnRedeemableConvertiblePreferredStock
23299000
CY2020 om Conversion Of Redeemable Convertible Preferred Stock Into Common Stock Upon Initial Public Offering
ConversionOfRedeemableConvertiblePreferredStockIntoCommonStockUponInitialPublicOffering
456561000
CY2020 om Reclassification Of Redeemable Convertible Preferred Stock Warrant Liability For Conversion Of Seriesa Warrants Into Common Stock Warrants
ReclassificationOfRedeemableConvertiblePreferredStockWarrantLiabilityForConversionOfSeriesaWarrantsIntoCommonStockWarrants
1252000
CY2020 om Reclassification Of Redeemable Convertible Preferred Stock Warrant Liability To Additional Paid In Capital
ReclassificationOfRedeemableConvertiblePreferredStockWarrantLiabilityToAdditionalPaidInCapital
3126000
CY2020 us-gaap Stock Issued1
StockIssued1
41763000
CY2018 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
788000
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses. These judgments, estimates and assumptions are used for, but not limited to, revenue recognition, allowance for doubtful accounts, inventory valuation and write-downs, warranty obligations, the fair value of common stock and redeemable convertible preferred stock, the fair value of stock options, the fair value of the redeemable convertible preferred stock warrant liability, valuation of investments, recoverability of the Company&#8217;s net deferred tax assets and the related valuation allowance, and certain accrued expenses. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results may differ from those estimates under different assumptions or conditions and the differences may be material. </p>
CY2020 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to a concentration of credit risk consist of cash and cash equivalents, restricted cash, short-term investments and accounts receivable. Substantially all the Company&#8217;s cash and cash equivalents, restricted cash and investments are held at one financial institution in the United States that management believes is of high credit quality. Such deposits may, at times, exceed federally insured limits or may not be covered by deposit insurance at all. The Company has not experienced any credit losses on its cash and cash equivalents, restricted cash or short-term investments through December&#160;31, 2020. </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the year ended December 31, 2020, three customers accounted for 22%, 19% and 16% of revenues, respectively. One customer accounted for 11% of revenues for the year ended December 31, 2019. Accounts receivable are unsecured and the Company does not require collateral; however, the Company does assess the collectability of accounts receivable based on a number of factors, including past transaction history with, and the creditworthiness of, the customer. Accordingly, the Company is exposed to credit risk associated with accounts receivable. Two customers accounted for 22% and 16% of accounts receivable, respectively, as of December 31, 2020. Four customers accounted for 22%, 13%, 11% and 10% of accounts receivable, respectively, as of December 31, 2019. To reduce risk, the Company closely monitors the amounts due from its customers and assesses the financial strength of its customers through a variety of methods that include, but are not limited to, engaging directly with customer operations and leadership personnel, visiting customer locations to observe operating activities, and assessing customer longevity and reputation in the marketplace. As a result, the Company believes that its accounts receivable credit risk exposure is limited. </p>
CY2020 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2003-05-05
CY2020Q3 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
254800000
CY2020Q3 om Offering Costs Underwriting Discounts And Commissions Expenses
OfferingCostsUnderwritingDiscountsAndCommissionsExpenses
23100000
CY2020 us-gaap Advertising Expense
AdvertisingExpense
0
CY2019 us-gaap Advertising Expense
AdvertisingExpense
0
CY2018 us-gaap Advertising Expense
AdvertisingExpense
0
CY2020Q4 us-gaap Change In Accounting Principle Accounting Standards Update Adopted
ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted
true
CY2020Q4 us-gaap Change In Accounting Principle Accounting Standards Update Adoption Date
ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate
2020-01-01
CY2020Q4 us-gaap Change In Accounting Principle Accounting Standards Update Immaterial Effect
ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect
true
CY2020 us-gaap Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
us-gaap:AccountingStandardsUpdate201813Member
CY2020Q4 om Operating Lease Arrangements Minimum Lease Payments Due Next Twelve Months
OperatingLeaseArrangementsMinimumLeasePaymentsDueNextTwelveMonths
4431000
CY2020Q4 om Operating Lease Arrangements Minimum Lease Payments Due Year Two
OperatingLeaseArrangementsMinimumLeasePaymentsDueYearTwo
1699000
CY2020 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
In September 2020, the Company’s board of directors and shareholders approved a certificate of amendment to the amended and restated certificate of incorporation to effect a reverse split of shares of the Company’s common stock on a 7.9-for-one basis (the Reverse Stock Split) effective as of September 8, 2020.
CY2020Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.126582
CY2020Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
314900000
CY2020Q4 om Cash Cash Equivalents Restricted Cash And Short Term Investments
CashCashEquivalentsRestrictedCashAndShortTermInvestments
348200000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
328283000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37669000
CY2020 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2019 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2020 om Warranty Period
WarrantyPeriod
P1Y
CY2020 om Capitalized Contract Cost Amortization Period Description
CapitalizedContractCostAmortizationPeriodDescription
The Company applies the practical expedient to expense the commissions as incurred as the expected amortization period is one year or less.
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
P3Y
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y
CY2020Q4 om Operating Lease Arrangements Minimum Lease Payments Due
OperatingLeaseArrangementsMinimumLeasePaymentsDue
6130000
CY2020Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
3800000
CY2020Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
3200000
CY2020Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
600000
CY2020Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2020Q4 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3771000
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1017000
CY2020 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
900000
CY2019 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
300000
CY2018 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
300000
CY2020 om Available For Sale Debt Securities Maturity Terms
AvailableForSaleDebtSecuritiesMaturityTerms
P1Y
CY2020Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
0
CY2019Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position
DebtSecuritiesAvailableForSaleUnrealizedLossPosition
0
CY2020Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
7989000
CY2019Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1143000
CY2020Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
6200000
CY2019Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
842000
CY2020Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
4195000
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2611000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
19986000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10565000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4988000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2670000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3200000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1500000
CY2018 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1100000
CY2020Q4 om Accrued Inventory Current
AccruedInventoryCurrent
3576000
CY2019Q4 om Accrued Inventory Current
AccruedInventoryCurrent
798000
CY2020Q4 om Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
175000
CY2019Q4 om Accrued Research And Development Expenses
AccruedResearchAndDevelopmentExpenses
421000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2187000
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
553000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1965000
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
1137000
CY2018Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
293000
CY2020 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
4858000
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
12667000
CY2019Q3 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
renewal options at the election of the Company to renew or extend the lease
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
13233000
CY2020Q4 om Long Term Debt Future Minimum Payments Due
LongTermDebtFutureMinimumPaymentsDue
36255000
CY2020Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
4230000
CY2020Q4 us-gaap Debt Current
DebtCurrent
2025000
CY2019 om Warrants Issued To Purchase Common Stock
WarrantsIssuedToPurchaseCommonStock
8860
CY2019 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
2578000
CY2020 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
3647000
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y
CY2019 om Warrants Issued To Purchase Common Stock Value
WarrantsIssuedToPurchaseCommonStockValue
30000
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.087
CY2019 om Warrants Issued To Purchase Common Stock Price Per Share
WarrantsIssuedToPurchaseCommonStockPricePerShare
8.61
CY2020Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
9118000
CY2020Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P0Y
CY2019Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P6M
CY2019 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
1169000
CY2019Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.106
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1619000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1796000
CY2018 us-gaap Lease Cost
LeaseCost
613000
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y3M18D
CY2020Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
326000
CY2019Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
939000
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
29674000
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
29061000
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
1141000
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
1141000
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
8073000
CY2019Q3 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2019Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
6000
CY2020Q4 om Operating And Finance Lease Right Of Use Assets
OperatingAndFinanceLeaseRightOfUseAssets
8253000
CY2019Q4 om Operating And Finance Lease Right Of Use Assets
OperatingAndFinanceLeaseRightOfUseAssets
6000
CY2019Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
9000
CY2020Q4 om Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
8926000
CY2019Q4 om Operating And Finance Lease Liability
OperatingAndFinanceLeaseLiability
9000
CY2020 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
6000
CY2019 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
13000
CY2018 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
10000
CY2019 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1000
CY2018 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1000
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
1070000
CY2018 us-gaap Operating Lease Cost
OperatingLeaseCost
505000
CY2020 us-gaap Variable Lease Cost
VariableLeaseCost
233000
CY2019 us-gaap Variable Lease Cost
VariableLeaseCost
100000
CY2018 us-gaap Variable Lease Cost
VariableLeaseCost
97000
CY2020 us-gaap Short Term Lease Cost
ShortTermLeaseCost
371000
CY2019 us-gaap Short Term Lease Cost
ShortTermLeaseCost
520000
CY2020 us-gaap Lease Cost
LeaseCost
1680000
CY2019 us-gaap Lease Cost
LeaseCost
634000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1856000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1911000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1969000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
2523000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
11674000
CY2020Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2748000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
8926000
CY2020Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
30000000
CY2019Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
30000000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
562000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1582000
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-20650000
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.043
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.078
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-26505000
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.049
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2020 om Share Based Compensation Arrangement By Share Based Payment Award Options Estimated Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsEstimatedGrantDateFairValue
8.00
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-42294000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.005
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.009
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-32043000
CY2020 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.234
CY2019 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.285
CY2018 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.272
CY2020Q4 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-32043000
CY2018 us-gaap Effective Income Tax Rate Reconciliation Tax Credits
EffectiveIncomeTaxRateReconciliationTaxCredits
0.020
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.006
CY2020 om Effective Income Tax Rate Reconciliation Nondeductible Permanent Expenses
EffectiveIncomeTaxRateReconciliationNondeductiblePermanentExpenses
0.004
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.014
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.012
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
-0.007
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
76838000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
56127000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
10039000
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
8777000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
2392000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
1675000
CY2020Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
19090000
CY2019Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
15553000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
2843000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
733000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
111202000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
82865000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
111202000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
82865000
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
28300000
CY2019 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
24000000
CY2018 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
13600000
CY2020Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
301300000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1020000
CY2020 us-gaap Significant Change In Unrecognized Tax Benefits Nature Of Event
SignificantChangeInUnrecognizedTaxBenefitsNatureOfEvent
The Company does not believe it is reasonably possible that its unrecognized tax benefits will significantly change within the next twelve months.
CY2020 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
362000
CY2019 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
134760000
CY2018 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
23300000
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4922000
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3757000
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3320000
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7190000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11742000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13756000
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
17247000
CY2020Q1 us-gaap Gross Profit
GrossProfit
-3564000
CY2020Q2 us-gaap Gross Profit
GrossProfit
-4764000
CY2020Q3 us-gaap Gross Profit
GrossProfit
-5126000
CY2020Q4 us-gaap Gross Profit
GrossProfit
417000
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
3387000
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-26505000
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-42294000
CY2020Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-32043000
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
4161000
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-26505000
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-42294000
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.77
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-4.58
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.44
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.75
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.74
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-4.58
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.44
CY2019Q4 om Net Income Loss Attributable To Common Stockholders Basic And Diluted
NetIncomeLossAttributableToCommonStockholdersBasicAndDiluted
-19446000
CY2019Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-30.34
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-18.93
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-18.93
CY2019Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-21.18
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.75
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2491000
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2872000
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2630000
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7085000
CY2019Q1 us-gaap Gross Profit
GrossProfit
-5258000
CY2019Q2 us-gaap Gross Profit
GrossProfit
-4470000
CY2019Q3 us-gaap Gross Profit
GrossProfit
-5294000
CY2019Q4 us-gaap Gross Profit
GrossProfit
-2780000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-16422000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-17029000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-15402000
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-19446000
CY2019Q1 om Net Income Loss Attributable To Common Stockholders Basic And Diluted
NetIncomeLossAttributableToCommonStockholdersBasicAndDiluted
-24292000
CY2019Q2 om Net Income Loss Attributable To Common Stockholders Basic And Diluted
NetIncomeLossAttributableToCommonStockholdersBasicAndDiluted
-25057000
CY2019Q3 om Net Income Loss Attributable To Common Stockholders Basic And Diluted
NetIncomeLossAttributableToCommonStockholdersBasicAndDiluted
-16666000

Files In Submission

Name View Source Status
0001564590-21-014563-index-headers.html Edgar Link pending
0001564590-21-014563-index.html Edgar Link pending
0001564590-21-014563.txt Edgar Link pending
0001564590-21-014563-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
go1rya10uhqx000001.jpg Edgar Link pending
go1rya10uhqx000002.jpg Edgar Link pending
go1rya10uhqx000003.jpg Edgar Link pending
go1rya10uhqx000004.jpg Edgar Link pending
go1rya10uhqx000005.jpg Edgar Link pending
go1rya10uhqx000006.jpg Edgar Link pending
go1rya10uhqx000007.jpg Edgar Link pending
go1rya10uhqx000008.jpg Edgar Link pending
go1rya10uhqx000009.jpg Edgar Link pending
go1rya10uhqx000010.jpg Edgar Link pending
go1rya10uhqx000011.jpg Edgar Link pending
go1rya10uhqx000012.jpg Edgar Link pending
go1rya10uhqx000013.jpg Edgar Link pending
go1rya10uhqx000014.jpg Edgar Link pending
om-10k_20201231.htm Edgar Link pending
om-20201231.xml Edgar Link completed
om-20201231.xsd Edgar Link pending
om-20201231_cal.xml Edgar Link unprocessable
om-20201231_def.xml Edgar Link unprocessable
om-20201231_lab.xml Edgar Link unprocessable
om-20201231_pre.xml Edgar Link unprocessable
om-ex1029_368.htm Edgar Link pending
om-ex1030_320.htm Edgar Link pending
om-ex105_323.htm Edgar Link pending
om-ex106_322.htm Edgar Link pending
om-ex107_321.htm Edgar Link pending
om-ex108_319.htm Edgar Link pending
om-ex231_367.htm Edgar Link pending
om-ex311_288.htm Edgar Link pending
om-ex312_287.htm Edgar Link pending
om-ex321_286.htm Edgar Link pending
om-ex45_324.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending